Stay updated with breaking news from Johan Dalsgaard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs),...
The new results show stabilization of disease already from week 6 and confirm the unprecedented increase in lung function over timeVicore will accelerate clinical developmentInvitation to conference
/PRNewswire/ -- Vicore Pharma Holding AB (publ) ('Vicore') pioneering development of angiotensin II type 2 receptor agonists (ATRAGs), today announces positive...
GOTHENBURG, Sweden, Sept. 22, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a...
GOTHENBURG, Sweden, Aug. 19, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2